Stanford
University
  • Stanford Home
  • Maps & Directions
  • Search Stanford
  • Emergency Info
  • Terms of Use
  • Privacy
  • Copyright
  • Trademarks
  • Non-Discrimination
  • Accessibility
© Stanford University.  Stanford, California 94305.

Healthcare AI Policy

AI has the potential to transform healthcare delivery yet there is an urgent need for governance processes to guide the safe, fair, and secure adoption of AI in clinical settings. Stanford HAI’s multidisciplinary Healthcare AI Policy Steering Committee conducts research and convenes discussions to develop tangible recommendations for policymakers.

Healthcare AI Policy Steering Committee

Latest News

Policy Briefs

Latest Research Papers

About

Stanford HAI’s Healthcare AI Policy Steering Committee is a multidisciplinary committee of Stanford faculty and scholars that are working together to advance the governance of healthcare AI. The group brings together academics, physicians, lawyers, computer scientists, and ethicists who believe deeply in both the power of AI applications to transform healthcare delivery and the urgent need to review existing regulatory frameworks to ensure these tools are safe, fair, and secure for clinical use.

By conducting interdisciplinary, evidence-based research and convening multi-stakeholder discussions, the committee aims to develop tangible recommendations for policymakers that help ensure healthcare AI can benefit patients, doctors, and developers alike.

Every year — as part of Stanford’s Health AI Week — the committee convenes a closed-door policy workshop to discuss policy challenges with a select group of leading policymakers, scientists, healthcare providers, ethicists, AI developers, and patient advocates. 

In May 2024, participants discussed gaps in federal policy related to AI software for clinical decision support, healthcare enterprise AI tools, and patient-facing AI.

In June 2025, the focus was on patient perspectives as participants explored policy challenges in AI-related payment policy, insurance decisions, and patient trust.

In June 2026, the discussion focused on emerging efforts to regulate the use of AI in mental health, for therapy and emotional support.

Our committee members publish timely research at the intersection of healthcare, law, policy, ethics, and AI. We highlight a selection of their latest research papers at the bottom of this page.

Michelle Mello
Chair of the Healthcare AI Policy Steering Committee | Professor of Law, Stanford Law School | Professor of Health Policy, Stanford University
Ehsan Adeli
Assistant Professor of Psychiatry and Behavioral Sciences and, by courtesy, of Computer Science and of Biomedical Data Science, Stanford University
Russ Altman
Russ Altman
Kenneth Fong Professor of Bioengineering, Genetics, Medicine, Biomedical Data Science, and, by courtesy, of Computer Science, Stanford University | Associate Director and Senior Fellow, Stanford HAI
headshot
Elena Cryst
Director of Policy and Society at Stanford HAI
Roxana Daneshjou
Assistant Professor of Biomedical Data Science and of Dermatology and, by courtesy, of Radiology, Stanford University
Diliana Funtarova
Master’s Candidate, Clinical Informatics Management, Stanford University
Curt Langlotz headshot
Curtis Langlotz
Senior Associate Vice Provost for Research, Stanford University | Professor of Radiology, Medicine, and Biomedical Data Science, Stanford University | Senior Fellow, Stanford HAI
Kara Liu
PhD Candidate, Computer Science, Stanford University
David Magnus
Thomas A. Raffin Professor of Medicine and Biomedical Ethics, Pediatrics and Medicine, and, by courtesy, of Bioengineering, Stanford University
Josh Makower
Yock Family Professor of Medicine and of Bioengineering, Stanford University | Director, Stanford Mussallem Center for Biodesign
Nicole Martinez-Martin
Assistant Professor of Pediatrics and, by courtesy, of Psychiatry and Behavioral Sciences, Stanford University

headshot
Caroline Meinhardt
Senior Policy Research Manager at Stanford HAI
Jared Moore
PhD Candidate, Computer Science, Stanford University
Douglas Owens
Henry J. Kaiser, Jr. Professor, and Professor and Chair of the Department of Health Policy, Stanford University | Director, Center for Health Policy in the Freeman Spogli Institute for International Studies, Stanford University
Sherri Rose
Professor of Health Policy and, by courtesy, of Computer Science, Stanford University | Director, Health Policy Data Science Lab, Stanford University
Sandra Waugh Ruggles
Director of Policy Research, Stanford Mussallem Center for Biodesign
Kevin Schulman
Professor of Medicine, Stanford University | Professor, by courtesy, of Operations, Information and Technology, Stanford Graduate School of Business
Sara Singer
Professor of Health Policy, of Medicine, and, (by courtesy, of Organizational Behavior at the Graduate School of Business, Stanford University
drew spence
Drew Spence
Policy Program Manager at Stanford HAI
Artem A. Trotsyuk
Artem Trotsyuk
AI Fellow in the Department of Genetics, Stanford University | AI Special Projects Fellow, Hoover Institution
Caroline Yee
Predoctoral Research Fellow, Stanford HAI
Maame Yaa A. B. Yiadom
Maya Yiadom
Associate Professor of Emergency Medicine, Stanford University

View All

View All

Navigate
  • About
  • Events
  • AI Glossary
  • Careers
  • Search
Participate
  • Get Involved
  • Support HAI
  • Contact Us

Stay Up To Date

Get the latest news, advances in research, policy work, and education program updates from HAI in your inbox weekly.

Sign Up For Latest News

Skip to content
  • About

    • About
    • People
    • Get Involved with HAI
    • Support HAI
    • Subscribe to Email
  • Research

    • Research
    • Research Programs
    • Grants
    • Marlowe (opens in new tab)
    • Student Affinity Groups
    • Centers & Labs
    • Research Publications
    • Research Partners
  • Education

    • Education
    • Executive and Professional Education
    • Government and Policymakers
    • K-12
    • Stanford Students
  • Policy

    • Policy
    • Policy Publications
    • Policymaker Education
    • Student Opportunities
  • AI Index

    • AI Index
    • AI Index Report
    • Global Vibrancy Tool
    • People
  • News
  • Events
  • Industry
  • Centers & Labs
Healthcare AI Policy | Stanford HAI

Russ Altman’s Testimony Before the U.S. Senate Committee on Health, Education, Labor, and Pensions

Russ Altman highlights opportunities for congressional support to make AI applications for patient care and drug discovery stronger, safer, and human-centered

Michelle M. Mello's Testimony Before the U.S. House Committee on Energy and Commerce Health Subcommittee

In this testimony presented to the U.S. House Committee on Energy and Commerce’s Subcommittee on Health hearing titled “Examining Opportunities to Advance American Health Care through the Use of Artificial Intelligence Technologies,” Michelle M. Mello calls for policy changes that will promote effective integration of AI tools into healthcare by strengthening trust.
Response to Request

Response to FDA’s Request for Feedback on Considerations for the Regulation of GenAI-Enabled Medical Devices

Roxana Daneshjou
Debadutta (Dev) Dash
Diliana Funtarova
Curt Langlotz headshot
+12
Roxana Daneshjou
HealthcareRegulation, Policy, GovernanceGenerative AIQuick ReadOct 19

Stanford scholars respond to a federal request for feedback, offering policy recommendations for the regulation of generative AI-enabled medical devices.

Operationalizing Real-Time Monitoring of Clinical AI
Zhongnan Fang, Lina Cheuy, Hye Sun Na, Akshay Chaudhari, David B. Larson
Quick ReadMay 14
Policy Brief

This brief demonstrates how real-time monitoring can address critical gaps in the oversight of radiological AI tools.

Toward Responsible AI in Health Insurance Decision-Making
Michelle Mello, Artem Trotsyuk, Abdoul Jalil Djiberou Mahamadou, Danton Char
Quick ReadFeb 10
Policy Brief

This brief proposes governance mechanisms for the growing use of AI in health insurance utilization review.

Response to FDA's Request for Comment on AI-Enabled Medical Devices
Desmond C. Ong, Jared Moore, Nicole Martinez-Martin, Caroline Meinhardt, Eric Lin, William Agnew
Quick ReadDec 02
Response to Request

Stanford scholars respond to a federal RFC on evaluating AI-enabled medical devices, recommending policy interventions to help mitigate the harms of AI-powered chatbots used as therapists.

Russ Altman’s Testimony Before the U.S. Senate Committee on Health, Education, Labor, and Pensions
Russ Altman
Quick ReadOct 09
Testimony

In this testimony presented to the U.S. Senate Committee on Health, Education, Labor, and Pensions hearing titled “AI’s Potential to Support Patients, Workers, Children, and Families,” Russ Altman highlights opportunities for congressional support to make AI applications for patient care and drug discovery stronger, safer, and human-centered.

The Healthcare Policies of the November 2026 Candidates
David Scheinker, Kevin Schulman, Anton Backer, Maya Shah
Quick ReadOct 20
Research
Your browser does not support the video tag.

Recent polls show that healthcare costs are a top affordability concern for American adults and that a large majority of adults, 90% of Democrats and 75% of Republicans, support a fundamental redesign or major changes to our healthcare system. Across states, political parties, and different types of office, politicians and constituents hold different views on healthcare policies and support different proposals. Various stakeholders such as patients, physicians, nurses, veterans, employers, and industry groups could potentially benefit from access to data on how their representatives’ views align with their own. There is no systematic, openly available database and analysis of these views. We sought to create the first systematic, openly available database and analysis of the healthcare policies and proposals of the leading candidates in the November 2026 elections and beyond.

The Healthcare Policies of the November 2026 Candidates

David Scheinker, Kevin Schulman, Anton Backer, Maya Shah
Quick ReadOct 20

Recent polls show that healthcare costs are a top affordability concern for American adults and that a large majority of adults, 90% of Democrats and 75% of Republicans, support a fundamental redesign or major changes to our healthcare system. Across states, political parties, and different types of office, politicians and constituents hold different views on healthcare policies and support different proposals. Various stakeholders such as patients, physicians, nurses, veterans, employers, and industry groups could potentially benefit from access to data on how their representatives’ views align with their own. There is no systematic, openly available database and analysis of these views. We sought to create the first systematic, openly available database and analysis of the healthcare policies and proposals of the leading candidates in the November 2026 elections and beyond.

Healthcare
Regulation, Policy, Governance
Your browser does not support the video tag.
Research
Roles for AI in Implementation of Medicaid Work Requirements
Michelle Mello, Himaja Nagireddy
Quick ReadSep 03
Research
Your browser does not support the video tag.

By January 2027, 44 state Medicaid programs must redetermine the eligibility of millions of beneficiaries under criteria in the 2025 budget reconciliation law (HR 1). Among the changes are “community engagement” (work) requirements and increased redetermination cadence (from annual to at least semiannual). In preparation, state Medicaid agencies have been exploring technological solutions to automate redeterminations at scale, including artificial intelligence (AI). Six agencies have decided to use AI tools so far and 21 states are considering use of them. Strategic deployment of AI can help states tackle the redetermination juggernaut, but overly broad or hasty deployment could compound the harms of HR 1.

Roles for AI in Implementation of Medicaid Work Requirements

Michelle Mello, Himaja Nagireddy
Quick ReadSep 03

By January 2027, 44 state Medicaid programs must redetermine the eligibility of millions of beneficiaries under criteria in the 2025 budget reconciliation law (HR 1). Among the changes are “community engagement” (work) requirements and increased redetermination cadence (from annual to at least semiannual). In preparation, state Medicaid agencies have been exploring technological solutions to automate redeterminations at scale, including artificial intelligence (AI). Six agencies have decided to use AI tools so far and 21 states are considering use of them. Strategic deployment of AI can help states tackle the redetermination juggernaut, but overly broad or hasty deployment could compound the harms of HR 1.

Healthcare
Regulation, Policy, Governance
Your browser does not support the video tag.
Research
Addressing Medical Affordability Without Compromising Care
Kevin Schulman, Ezekiel J. Emanuel, MD, PhD
Quick ReadJul 09
Research
Your browser does not support the video tag.

The US spends 25 percent of all health care costs on administration, a big part of which involves billing for medical services. To realize savings requires standardizing and digitizing billing.

Addressing Medical Affordability Without Compromising Care

Kevin Schulman, Ezekiel J. Emanuel, MD, PhD
Quick ReadJul 09

The US spends 25 percent of all health care costs on administration, a big part of which involves billing for medical services. To realize savings requires standardizing and digitizing billing.

Healthcare
Regulation, Policy, Governance
Your browser does not support the video tag.
Research
Utah's Experiment With AI-Driven Prescription Renewals
Michelle Mello
Quick ReadMar 19
Research
Your browser does not support the video tag.

In January 2026, Utah announced a first-of-its kind pilot program allowing an autonomous artificial intelligence (AI) agent to renew prescriptions for consumers who request it. The state agreed not to enforce its unprofessional conduct laws against the developer, Doctronic, if the company adheres to a contract that includes safety and privacy protections. The pilot program includes 192 drugs for chronic conditions. Although physicians will initially validate the AI’s actions, the pilot program will swiftly become one of the first deployments at scale of an autonomous, agentic system in medicine. The announcement prompted concern from associations of physicians and pharmacists who opined that AI “should NOT be making care decisions.”

Utah's Experiment With AI-Driven Prescription Renewals

Michelle Mello
Quick ReadMar 19

In January 2026, Utah announced a first-of-its kind pilot program allowing an autonomous artificial intelligence (AI) agent to renew prescriptions for consumers who request it. The state agreed not to enforce its unprofessional conduct laws against the developer, Doctronic, if the company adheres to a contract that includes safety and privacy protections. The pilot program includes 192 drugs for chronic conditions. Although physicians will initially validate the AI’s actions, the pilot program will swiftly become one of the first deployments at scale of an autonomous, agentic system in medicine. The announcement prompted concern from associations of physicians and pharmacists who opined that AI “should NOT be making care decisions.”

Healthcare
Regulation, Policy, Governance
Your browser does not support the video tag.
Research
The AI Arms Race In Health Insurance Utilization Review: Promises Of Efficiency And Risks Of Supercharged Flaws
Michelle Mello, Artem Trotsyuk, Abdoul Jalil Djiberou Mahamadou, Danton Char
Quick ReadJan 06
Research
Your browser does not support the video tag.

Health insurers and health care provider organizations are increasingly using artificial intelligence (AI) tools in prior authorization and claims processes. AI offers many potential benefits, but its adoption has raised concerns about the role of the “humans in the loop,” users’ understanding of AI, opacity of algorithmic determinations, underperformance in certain tasks, automation bias, and unintended social consequences. To date, institutional governance by insurers and providers has not fully met the challenge of ensuring responsible use. However, several steps could be taken to help realize the benefits of AI use while minimizing risks. Drawing on empirical work on AI use and our own ethical assessments of provider-facing tools as part of the AI governance process at Stanford Health Care, we examine why utilization review has attracted so much AI innovation and why it is challenging to ensure responsible use of AI. We conclude with several steps that could be taken to help realize the benefits of AI use while minimizing risks.

The AI Arms Race In Health Insurance Utilization Review: Promises Of Efficiency And Risks Of Supercharged Flaws

Michelle Mello, Artem Trotsyuk, Abdoul Jalil Djiberou Mahamadou, Danton Char
Quick ReadJan 06

Health insurers and health care provider organizations are increasingly using artificial intelligence (AI) tools in prior authorization and claims processes. AI offers many potential benefits, but its adoption has raised concerns about the role of the “humans in the loop,” users’ understanding of AI, opacity of algorithmic determinations, underperformance in certain tasks, automation bias, and unintended social consequences. To date, institutional governance by insurers and providers has not fully met the challenge of ensuring responsible use. However, several steps could be taken to help realize the benefits of AI use while minimizing risks. Drawing on empirical work on AI use and our own ethical assessments of provider-facing tools as part of the AI governance process at Stanford Health Care, we examine why utilization review has attracted so much AI innovation and why it is challenging to ensure responsible use of AI. We conclude with several steps that could be taken to help realize the benefits of AI use while minimizing risks.

Healthcare
Regulation, Policy, Governance
Your browser does not support the video tag.
Research
AI, Health, and Health Care Today and Tomorrow: The JAMA Summit Report on Artificial Intelligence
Tina Hernandez-Boussard, Michelle Mello, Nigam Shah, Co-authored by 50+ experts
Deep DiveOct 13
Research
Your browser does not support the video tag.

AI, Health, and Health Care Today and Tomorrow: The JAMA Summit Report on Artificial Intelligence

Tina Hernandez-Boussard, Michelle Mello, Nigam Shah, Co-authored by 50+ experts
Deep DiveOct 13
Healthcare
Regulation, Policy, Governance
Your browser does not support the video tag.
Research
news
digital face mental health illustration

The Complexities of Governing Mental Health AI

Caroline Yee, Caroline Meinhardt, Michelle Mello, Jane Paik Kim
HealthcarePrivacy, Safety, SecurityGenerative AIRegulation, Policy, GovernanceJul 24

Policymakers, academics, healthcare providers, AI developers, and patient advocates convened by Stanford HAI identify critical gaps in how we regulate AI tools used for therapy and emotional support.